Biological Dynamics, an early detection disease management company, expands leadership
SAN DIEGO, Nov. 10, 2022 /PRNewswire/ -- Biological Dynamics, an exosome isolation technology and early disease detection company, today announced new executive appointments to fuel its growth.
- SAN DIEGO, Nov. 10, 2022 /PRNewswire/ -- Biological Dynamics, an exosome isolation technology and early disease detection company, today announced new executive appointments to fuel its growth.
- Nall leads the commercialization strategy of the Laboratory Developed Tests (LDTs) to detect the early stages of cancer.
- As the company prepares for growth, Michael Russell has replaced Biological Dynamics' cofounder, Dr. Raj Krishnan, as a director.
- Our team is driven every day to bring innovative solutions to patients, their families and the biomedical community with a focus on early diagnostic disease detection applications, particularly in cancer.